Calcipotriene and Vitiligo

Archives of Dermatology

Volumn 139, Issue 12, 2003, Pages 1656-1657

  Vázquez López, Francisco ^a   López Escobar, María ^b   Pérez Oliva, Narciso ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; PSORALEN; VITAMIN D DERIVATIVE;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXPECTATION; HUMAN; HYPERPIGMENTATION; MELANOCYTE; NOTE; PIGMENTATION; PILOT STUDY; PRIORITY JOURNAL; PSORIASIS; PUVA; SIDE EFFECT; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO;

ADMINISTRATION, TOPICAL; CALCITRIOL; DERMATOLOGIC AGENTS; HUMANS; PILOT PROJECTS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 0346874284     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.12.1656     Document Type: Note

References (6)

1. Dogra S, Parsad D. Combination of narrowband UV-B and topical calcipotriene in vitiligo. Arch Dermatol. 2003;139:393.
2. Vázquez-López F, Pérez-Oliva N. Transient hyperpigmentation after calcipotriol ointment and PUVA therapy in psoriatic patients. Acta Derm Venereol. 1996;76:400.
3. Glasser R, Rowert J, Mrowietz U. Hyperpigmentation due to topical calcipotriol and photochemotherapy in two psoriatic patients. Br J Dermatol. 1998;139:148-151.
4. Pérez-Oliva N, Váquez-López F. Calcipotriol y vitiligo. Piel. 2001;16:74.
5. Yalcin B, Sahin S, Bükülmez G et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol. 2001;44:634-637.
6. Baysal V, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol. 2003;17:299-302.